RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones
- Conditions
- CholecystectomyComplicationGallbladder Stones
- Interventions
- Procedure: cholecystectomyOther: gallbladder preserved
- Registration Number
- NCT03577873
- Lead Sponsor
- First People's Hospital of Hangzhou
- Brief Summary
To discuss necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.
- Detailed Description
Cholecystectomy was recommended for patients with stones in their bile ducts and gallbladders in European and American countries after clearance of bile duct stones with ERCP, which reduced the incidence of biliary events. However, some researches showed that the incidence of biliary events was not reduced but increased.The purpose of this study is to discuss the necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
Obtention of a written informed consent; Clinical diagnosis of gallbladder stones and common bile duct stones; No absolute operation indications of cholecystectomy
Intrahepatic stones; Malignant tumor disease ;
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description cholecystectomy cholecystectomy Patients with stones in their bile ducts and gallbladders will undergo cholecystectomy after clearance of bile duct stones with ERCP. gallbladder preserved gallbladder preserved Patients with stones in their bile ducts and gallbladders will keep gallbladders in stay after clearance of bile duct stones with ERCP.
- Primary Outcome Measures
Name Time Method biliary events 12 months The incidence of biliary events will be compared in the two groups.
- Secondary Outcome Measures
Name Time Method adverse events 12 months Number of participants with adverse events: type, frequency and intensity of adverse events.
Trial Locations
- Locations (1)
Hangzhou First People's Hospital
🇨🇳Hangzhou, Zhejiang, China